Comparing two liquid hydrocortisone versions for children
Part of Hormones & metabolism clinical trials.
This trial tests two different ways of making a liquid hydrocortisone medicine for children with adrenal gland problems. It looks at which one is easier to take and causes fewer side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Child is between 6 and 17 years old.
- Child can swallow pills or liquids without problems.
- Child has been diagnosed with adrenal hyperplasia, primary adrenal insufficiency, or panhypopituitarism.
- No known allergy to any ingredient in the hydrocortisone medication.
- Child is stable enough to take the medication as prescribed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two medications, hydrocortisone and methylprednisolone, to see which works better for people whose adrenal glands have stopped working properly after taking high doses of steroids (methylprednisolone) for more than 4 weeks.
This trial tests whether hydrocortisone (a cortisol replacement) helps people who feel symptoms of adrenal insufficiency after they stop long-term prednisolone. It compares hydrocortisone versus placebo to see if symptoms improve and dosing is safer/effective.
This study tests whether adding supplemental hydrocortisone during stressful events can prevent problems in people who develop adrenal insufficiency from long-term prednisolone. It is meant to see if “stress dosing” is safer and helps the body respond to stress.
This study checks hormone levels in saliva and blood using a precise test to better understand how the body balances steroids in people with congenital adrenal hyperplasia, a condition that affects hormone production.
This trial studies whether a once-daily hydrocortisone tablet works as well as standard steroid treatment for adults with congenital adrenal hyperplasia caused by 21-hydroxylase deficiency. It aims to improve how safely and conveniently hormone replacement is taken each day.
This study follows adults with a genetic condition called congenital adrenal hyperplasia (CAH) who are switching to a new form of the steroid medication hydrocortisone. Researchers will track how well this modified-release version—which releases medication slowly over time—works for managing their condition in real-world practice.
Hear when a new Adrenal Insufficiency trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.